SGF29 and leukemia: We showed that depletion of Sgf29 delayed the leukemia development in the recipient mice (Fig. 2E) with a decreased engraftment of CD45.2+ leukemic cells into peripheral blood and spleen of the recipient mice (Fig. 2F).